Prophylaxis or preemptive therapy of invasive candidiasis in the intensive care unit?

Critical Care Medicine

Volumn 32, Issue 12, 2004, Pages 2552-2553

  Ostrosky Zeichner, Luis ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Intensive care unit; Invasive candidiasis; Preemptive therapy; Prophylaxis; Risk; Surveillance cultures

Indexed keywords

FLUCONAZOLE;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; CANDIDA; CANDIDIASIS; CLINICAL TRIAL; EDITORIAL; HUMAN; INCIDENCE; INFECTION RISK; INTENSIVE CARE UNIT; LENGTH OF STAY; PRIORITY JOURNAL; PROPHYLAXIS;

CANDIDIASIS; CASE-CONTROL STUDIES; CRITICAL CARE; CROSS INFECTION; FEMALE; FLUCONAZOLE; FUNGEMIA; HUMANS; INTENSIVE CARE UNITS; MALE; PRIMARY PREVENTION; PROGNOSIS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 10644252708     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000148226.95597.7E     Document Type: Editorial

References (20)

1. Jarvis WR: Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995; 20:1526-1530
2. Kullberg BJ, Oude Lashof AM: Epidemiology of opportunistic invasive mycoses. Eur J Med Res 2002; 7:183-191
3. Leleu G, Aegerter P, Guidet B: Systemic candidiasis in intensive care units: A multicenter, matched-cohort study. J Crit Care 2002; 17:168-175
4. Rangel-Frausto MS, Wiblin T, Blumberg HM, et al: National epidemiology of mycoses survey (NEMIS): Variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 1999; 29:253-258
5. Wenzel RP: Nosocomial candidemia: Risk factors and attributable mortality. Clin Infect Dis 1995; 20:1531-1534
6. Marchetti O, Bille J, Fluckiger U, et al: Epidemiology of candidemia in Swiss tertiary care hospitals: Secular trends, 1991-2000. Clin Infect Dis 2004; 38:311-320
7. Diekema DJ, Messer SA, Brueggemann AB, et al: Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol 2002; 40:1298-1302
8. Gudlaugsson O, Gillespie S, Lee K, et al: Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003; 37:1172-1177
9. Rentz AM, Halpern MT, Bowden R: The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. Clin Infect Dis 1998; 27:781-788
10. Piarroux R, Grenouillet F, Balvay P, et al: Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med 2004; 32:2443-2449
11. Ascioglu S, Rex JH, de Pauw B, et al: Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin Infect Dis 2002; 34:7-14
12. Pittet D, Monod M, Suter PM, et al: Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994; 220:751-758
13. Blumberg HM, Jarvis WR, Soucie JM, et al: Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 2001; 33:177-186
14. Eggimann P, Garbino J, Pittet D: Management of Candida species infections in critically ill patients. Lancet Infect Dis 2003; 3:772-785
15. Pappas PG, Rex JH, Sobel JD, et al: Guidelines for treatment of candidiasis. Clin Infect Dis 2004; 38:161-189
16. Rex JH, Sobel JD: Prophylactic antifungal therapy in the intensive care unit. Clin Infect Dis 2001; 32:1191-1200
17. Pelz RK, Hendrix CW, Swoboda SM, et al: Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 2001; 233:542-548
18. Garbino J, Lew DP, Romand JA, et al: Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients: A randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med 2002; 28:1708-1717
19. Ostrosky-Zeichner L, Sable C, Sobel J, et al: Multicenter retrospective development and validation of a clinical prediction rule for invasive candidiasis (IC) in the intensive care setting. Abstr 51. In: Focus on Fungal Infections 14. New Orleans, 2004
20. Dupont H, Bourichon A, Paugam-Burtz C, et al: Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis? Crit Care Med 2003; 31:752-757